Formycon : announces improved preliminary figures for the 2025 fiscal year and sets date for the publication of the annual financial statements

About this update from Formycon Ag

Disclosure of inside information according to Article 17 of the Regulation (EU) No 596/2014 Group EBITDA of approx. € -4 million (vs. € -12 million) and adjusted EBITDA of approx. € -2 million (vs. € -7 million), better than previously communicated Group revenue unchanged at approx. € 45 million Group working capital of approx. € 70 million (vs. € 73 million) slightly below preliminary estimates but above the forecast Planegg-Martinsried, Germany, April 15, 2026 - Formycon AG (ISIN: DE000A1EWVY8/ WKN: A1EWVY) (" Company " or " Formycon ") announces that, as part of the final preparation of the annual financial statements for the 2025 fiscal year, changes have occurred in the key performance indicators Group EBITDA and Group adjusted EBITDA, as well as in working capital, compared to the preliminary figures published on March 4, 2026. Based on the information currently available, the Company expects significantly better Group's earnings before interest, taxes, depreciation and amortization (Group EBITDA) as well as clearly higher adjusted consolidated earnings before depreciation and amortization (Group adjusted EBITDA) than previously communicated. The improvements in Group EBITDA from the originally reported € -12 million to approximately € -4 million and in Group adjusted EBITDA from the originally reported € -7 million to approximately € -2 million result primarily from an adjustment to the accounting approach of development investments. These adjustments also have an impact on the working capital, which now amounts to approximately € 70 million, slightly below the previous preliminary estimate (approximately € 73 million) but significantly above the forecast (€ 55 million to € 65 million). Preliminary Group revenues remain unchanged at approx. € 45 million. Likewise, there have been no changes to the previously communicated impairment test for FYB202. The final financial figures and further information on the 2025 financial year as well as the outlook for 2026 will be published on April 22, 2026 with the annual report for the 2025 financial year on the website under Publications - Formycon AG Disclaimer Certain statements contained in this release may constitute "forward-looking statements" that involve a number of risks and uncertainties. Forward-looking statements can generally be identified by the use of the words "may," "will," "should," "plan," "expect," "anticipate," "estimate," "believe," "intend," "project," or "aim," or the negative of these words or other variations of these words or comparable terminology. Forward-looking statements are based on assumptions, forecasts, estimates, projections, opinions or plans that, by their nature, are subject to significant risks and uncertainties and contingencies that are subject to change. Formycon does not and will not give any assurance that any forward-looking statement will be achieved or prove to be accurate. Actual future business, financial condition, results of operations and prospects may differ materially from those projected or anticipated in the forward-looking statements. Subject to applicable legal requirements, neither Formycon nor any other person intends to update, review, revise or revise any forward-looking statements in this release to reflect actual events or developments, whether as a result of new information becoming available, new developments occurring in the future or otherwise, nor does it undertake any such obligation. Contact Formycon AG Fraunhoferstraße 15・82152 Planegg/Martinsried Germany T + 49 89 86 46 67 149・F + 49 89 86 46 67 110 [email protected]

View stock analysis, news, and events for Formycon Ag